Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3682048014 | Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3682049018 | Product containing precisely metformin hydrochloride 500 milligram and pioglitazone hydrochloride 15 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | est un(e) (attribut) | Metformin and pioglitazone only product in oral dose form | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | est un(e) (attribut) | Product containing metformin and pioglitazone (medicinal product) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a pour principe actif (attribut) | Pioglitazone (substance) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a une forme pharmaceutique (attribut) | comprimé | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a pour principe actif (attribut) | Metformin (substance) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a pour principe actif (attribut) | Thiazolidinedione (substance) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a une forme pharmaceutique (attribut) | Oral tablet | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a pour principe actif (attribut) | Metformin hydrochloride | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a pour principe actif (attribut) | Pioglitazone hydrochloride | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | est un(e) (attribut) | Metformin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a pour principe actif (attribut) | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has basis of strength substance (attribute) | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength numerator value (attribute) | 500 (qualifier value) | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | a pour principe actif (attribut) | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has basis of strength substance (attribute) | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength numerator value (attribute) | 15 (qualifier value) | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has precise active ingredient | Pioglitazone hydrochloride | false | Inferred relationship | Some | 2 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Has precise active ingredient | Metformin hydrochloride | false | Inferred relationship | Some | 1 | |
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | est un(e) (attribut) | Metformin- and pioglitazone-containing product in oral dose form | false | Inferred relationship | Some | ||
| Metformin hydrochloride 500 mg and pioglitazone hydrochloride 15 mg oral tablet | Count of base of active ingredient | deux | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR